TSVT's logo.
Ticker Symbol: TSVT

2seventy bio Inc

$37.27 - 20-12-2024 4 p.m. ET

Exchange: NASDAQ Currency: USD Asset Type: Common Stock CIK:0001860782

Company Profile

Its name, 2seventy bio, reflects why 2seventy bio does what 2seventy bio does - TIME. Cancer rips time away and its goal is to work at the maximum speed of translating human thought into action – 270 miles per hour — to give the people 2seventy bio serve more time. 2seventy bio is building the leading immuno-oncology cell therapy company, focused on discovering and developing new therapies that truly disrupt the cancer treatment landscape. With a deep understanding of the human body’s immune response to tumor cells and how to translate cell therapies into practice, 2seventy bio’s applying this knowledge to deliver next generation cellular therapies that focus on a broad range of hematologic malignancies, including the first FDA-approved CAR T cell therapy for multiple myeloma, as well as solid tumors. Its research and development is focused on delivering therapies that are designed with the goal to "think" smarter and faster than the disease. Importantly, 2seventy bio remains focused on accomplishing these goals by staying genuine and authentic to its "why" and keeping its people and culture top of mind every day.

Sector: Manufacturing
Industry: Pharmaceutical Preparation Manufacturing
Standard Industrial Classification Code (SIC code): 2834
Address: N/A
CEO: N/A
Tags: N/A

Pricing

Last Updated: October 3, 2023 03:00 PM EST
Previous Close: $4.05
Change: $0.09 ( 2.27%)
Days Range: $3.72 - $4.09
Beta: 1.22
52wk. High: $17.55
52wk. Low: $3.01
Ytd. Change -55.36%
50 Day Moving Average: $4.00
200 Day Moving Average: $8.05
Shares Outstanding: 50464578

Valuation

Market Cap: 20.5B
PE Ratio: -0.97
EPS (TTM): -4.19

Dividends

Dividend Per Share (TTM): -
Dividend Yield (TTM): 0.00%
Ex-Dividend Date: N/A